| |
| |
|
| Insider
Information: |
Orwin John A |
| Relationship: |
|
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
214,417 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$200,241 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
214,417 |
|
|
| Total
Value |
$200,241 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
2
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-2.0
|
| Percentage
Gain/Loss : |
 19.8%
|
 -117.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Affymax Inc |
AFFY |
CEO, Director |
2013-02-01 |
108,000 |
2010-09-22 |
0 |
Premium* |
|
|
Relypsa Inc |
RLYP |
President & CEO, Direc... |
2016-09-01 |
0 |
2013-11-20 |
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2014-01-10 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
|
2024-05-08 |
28,875 |
2017-03-23 |
0 |
Premium* |
|
|
Atreca Inc |
BCEL |
|
2024-04-11 |
77,542 |
2020-03-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
75 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AFFY |
Affymax Inc |
President and COO |
• – – |
2010-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| AFFY |
Affymax Inc |
CEO |
• • – |
2011-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
160,000 |
0 |
- |
|
| AFFY |
Affymax Inc |
CEO |
• • – |
2013-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
108,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2014-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| RLYP |
Relypsa Inc |
President & CEO |
• • – |
2014-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
35,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2015-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
8,700 |
0 |
- |
|
| RLYP |
Relypsa Inc |
President & CEO |
• • – |
2015-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
47,500 |
0 |
- |
|
| RLYP |
Relypsa Inc |
President & CEO |
• • – |
2015-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,875 |
59,375 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
14,400 |
0 |
- |
|
| RLYP |
Relypsa Inc |
President & CEO |
• • – |
2016-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,625 |
60,000 |
0 |
- |
|
| RLYP |
Relypsa Inc |
President & CEO |
• • – |
2016-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
65,142 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2017-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,375 |
4,375 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2017-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
18,100 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2018-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
6,875 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2018-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
21,800 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2019-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
8,875 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
24,763 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
11,875 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,335 |
26,098 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
14,875 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,402 |
27,500 |
0 |
- |
|
| BCEL |
Atreca Inc |
President & CEO |
• • – |
2021-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
115,400 |
121,400 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
17,875 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,503 |
29,003 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
22,375 |
0 |
- |
|
75 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
